SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar (CSIQ) is trending due to widespread community allegations of market manipulation and a recent convertible notes offering, which many shareholders perceive as detrimental, fueling frustration over its valuation despite strategic moves in US manufacturing and IRA tax credit potential.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as its board rejected an "undervalued" CEO buyout offer and confirmed it's now evaluating multiple competitive acquisition proposals from major shipping players like Hapag-Lloyd and MSC. The community is buzzing with buyout speculation, anticipating a bidding war to unlock ZIM's substantial intrinsic value and cash reserves amidst rising container rates, despite Israeli regulatory and union concerns.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN CRYPTO is trending amid highly polarized community discussions, with supporters championing its "culture first" mission on Solana and the broader cannabis legalization movement, while critics widely label it as a pump-and-dump meme coin without intrinsic value.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits

PAW CRYPTO is trending as its community actively discusses recent AMA insights and a strategic brand refresh, highlighting its innovative Layer 3 architecture unifying liquidity across multiple chains and its forthcoming network relaunch in Q1 2026, positioning it as an undervalued long-term infrastructure play.

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Jazz Pharmaceuticals plc

Jazz Pharmaceuticals is surging after announcing strong Phase 3 clinical trial results for its cancer drug Ziihera in gastroesophageal cancer and receiving FDA accelerated approval for Ziihera in biliary tract cancer. This success has ignited investor confidence, fueling analyst upgrades and widespread community discussion about the drug's potential to establish a new standard of care in oncology.

Bridgford Foods Corp. engages in the manufacture, market, and distribution of frozen and snack food products. It operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment manufactures and distributes food products, including biscuits, bread dough items, roll dough items, and sandwiches. The Snack Food Products segment distributes both products manufactured by the company and third parties. The company was founded by Hugh H. Bridgford in February 1932 and is headquartered in Dallas, TX.

Bridgford Foods Corp.

Bridgford Foods Corporation

Bridgford Foods (BRID) is garnering significant attention as the community anticipates dramatically improved gross profit margins, driven by President Trump's initiative to increase beef imports, which is expected to considerably lower input costs. This potential catalyst, alongside accelerating private-label sales with major retailers, is fueling discussions about unlocking the microcap's deeply undervalued assets and inspiring speculation of a potential take-private transaction, further supported by consistent insider buying.

iShares Trust - iShares 0-3 Month Treasury Bond ETF

iShares 0-3 Month Treasury Bond ETF

SGOV is trending as investors, wary of high equity valuations and anticipating a potential market pullback, flock to park their capital in ultra-short-term U.S. Treasury bonds. Its attractive yield and liquidity offer a safe haven for cash while awaiting more favorable buying opportunities in the broader market.

Qualys, Inc. engages in the provision of cloud security and compliance solutions. Its products enable organizations to identify security risks to information technology infrastructures, help protect information technology systems and applications from cyber attacks, and achieve compliance with internal policies and external regulations. The firm also offers solutions through a software-as-a-service model, primarily with renewable annual subscriptions. The company was founded on December 30, 1999 and is headquartered in Foster City, CA.

Qualys Inc

Qualys Inc. is trending after its latest earnings report, which, despite beating quarterly expectations, led to a sharp stock drop due to a disappointing full-year revenue growth outlook. The community is actively debating if this significant dip presents a buying opportunity, particularly amid broader discussions about cybersecurity infrastructure's resilience against "AI replacement" concerns.

Featured in Matt Furies latest book Cortex Vortex as Ratos nemesis. The character is also part of ZOGZ which confirms its real name.  Matt Furie, the artist best known for creating Pepe the Frog, has been working on a new book. The news comes from his editor, who goes by the handle @beuys_on_sale_ on Instagram. In a recent post, the editor hinted at an upcoming project featuring new characters named Gasspas and Rato. Gasspas’s visual appearance can be inferred from the artwork. In one illustration, Gasspas is depicted looming over two rats (Rato and Wat), gazing down at them in a menacing way (an image that has circulated among collectors). This inferred that Gasspas is Ratos nemesis in the new book Cortex Vortex reinforced by community quips that “cats eat rats”. Gasspas debuted as part of ZOGZ, a collection of 111 original NFT character illustrations by Matt Furie launched in May 2023.

Gasspas

Gasspas ($GASS) is trending as the community speculates on its potential to be "the next PEPE," fueled by comparisons and discussions of alleged backing from PEPE creator Matt Furie. This narrative drives calls to buy and hold, even as some community members label it a pump and dump amidst volatile price action.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Equity Premium Income ETF

JPMorgan Equity Premium Income ETF

JPMorgan Equity Premium Income ETF ($JEPI) is actively discussed as investors prioritize consistent monthly income amidst market volatility, with many highlighting its defensive qualities and resilience during market dips. The community is debating its role in income-focused portfolios, often comparing its stability and dividend tax treatment against other high-yield covered call ETFs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the target of a large increase in short interest in January. As of January 30th, there was short interest totaling 76,808 shares, an increase of...

Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 68.3%

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totaling 53,042...

1,409,160 Shares in SOPHiA GENETICS SA $SOPH Bought by Alta Wealth Advisors LLC

Alta Wealth Advisors LLC purchased a new stake in SOPHiA GENETICS SA (NASDAQ:SOPH - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange...

SOPHiA GENETICS (NASDAQ:SOPH) Trading Down 0.7% - Here's What Happened

SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Down 0.7% - Here's Why...

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan SOPHiA GENETICS Provides Preliminary Fourth...

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 32,434 shares, a drop of...

SOPHiA GENETICS (NASDAQ:SOPH) Trading 2.8% Higher - What's Next?

SOPHiA GENETICS (NASDAQ:SOPH) Shares Up 2.8% - Here's What Happened...

AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave

AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave PR Newswire VANCOUVER, BC, Dec. 12, 2025 Issued...

321,527 Shares in SOPHiA GENETICS SA $SOPH Purchased by Archon Capital Management LLC

Archon Capital Management LLC bought a new stake in shares of SOPHiA GENETICS SA (NASDAQ:SOPH - Free Report) during the second quarter, according to the company in its most recent Form 13F filing...

Tempus AI's Data Business Is Expanding and Adding to Revenues: Here's How

TEM's surging Insights revenues, new contracts and expanded AI capabilities highlight its shift toward scalable data-driven growth.

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

SOPHiA Genetics SA

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.24	--	--	N/A
Q3 '25	-$0.23	-$0.30	-30.43%	MISSED
Q2 '25	-$0.21	-$0.33	-54.21%	MISSED
Q1 '25	-$0.22	-$0.26	-16.42%	MISSED
Q4 '24	-$0.20	-$0.23	-12.20%	MISSED

SOPH
SOPHiA Genetics SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SOPH News

SOPHSOPHiA Genetics SA